Stockreport

Natera and MyOme Announce Launch of iPRS™ for Breast Cancer Risk Assessment

Natera, Inc.  (NTRA) 
Last natera, inc. earnings: 2/26 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.natera.com
PDF Cross-ancestry polygenic risk score now offered with the Empower™ hereditary cancer test AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader [Read more]